Comment
doi: 10.1016/S0140-6736(12)60066-X.
Epub 2012 Jan 24.
What (if anything) to do about low-risk prostate cancer
Affiliations
- PMID: 22277569
- DOI: 10.1016/S0140-6736(12)60066-X
Item in Clipboard
Comment
What (if anything) to do about low-risk prostate cancer
Lancet.
.
No abstract available
Comment in
-
Dutasteride and active surveillance of low-risk prostate cancer.Lancet. 2012 Apr 28;379(9826):1590. doi: 10.1016/S0140-6736(12)60678-3. Epub 2012 Apr 26. Lancet. 2012. PMID: 22541581 No abstract available.
Comment on
-
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.Lancet. 2012 Mar 24;379(9821):1103-11. doi: 10.1016/S0140-6736(11)61619-X. Epub 2012 Jan 24. Lancet. 2012. PMID: 22277570 Clinical Trial.
Similar articles
-
Dutasteride and active surveillance of low-risk prostate cancer.Lancet. 2012 Apr 28;379(9826):1590. doi: 10.1016/S0140-6736(12)60678-3. Epub 2012 Apr 26. Lancet. 2012. PMID: 22541581 No abstract available.
-
Words of wisdom. Re: dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.Eur Urol. 2013 Jul;64(1):167. doi: 10.1016/j.eururo.2013.04.022. Eur Urol. 2013. PMID: 23746318 No abstract available.
-
Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies.Eur Urol. 2011 Feb;59(2):183-90. doi: 10.1016/j.eururo.2010.09.035. Epub 2010 Dec 4. Eur Urol. 2011. PMID: 21130560 Review.
-
Prostate cancer chemoprevention with 5α-reductase inhibitors.Urol Oncol. 2012 Sep;30(5):553-4. doi: 10.1016/j.urolonc.2011.02.006. Urol Oncol. 2012. PMID: 23193568 No abstract available.
-
Dutasteride for the treatment of prostate-related conditions.Expert Opin Drug Saf. 2012 Mar;11(2):325-30. doi: 10.1517/14740338.2012.658040. Epub 2012 Feb 8. Expert Opin Drug Saf. 2012. PMID: 22316171 Review.
Cited by
-
Potent increased risk of the initiation of DNA replication in human prostate cancer with the use of 5α-reductase inhibitors.Am J Clin Exp Urol. 2014 Jul 12;2(2):136-44. eCollection 2014. Am J Clin Exp Urol. 2014. PMID: 25374915 Free PMC article.
-
Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?Front Oncol. 2014 Sep 16;4:247. doi: 10.3389/fonc.2014.00247. eCollection 2014. Front Oncol. 2014. PMID: 25279351 Free PMC article. Review.
-
Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity.Sci Rep. 2013;3:1268. doi: 10.1038/srep01268. Sci Rep. 2013. PMID: 23429215 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
